Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Callahan

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterizationR D Schwarz, M J Callahan, L L Coughenour, et al.
The American Journal of Cardiology|February 1, 1985
Two-dimensional echocardiographically guided pericardiocentesis: experience in 117 consecutive patientsJ A Callahan, J B Seward, R A Nishimura, et al.
The American Journal of Pathology|November 14, 1997
Cerebral lipid deposition in aged apolipoprotein-E-deficient miceL C Walker, C A Parker, W J Lipinski, et al.
Molecular Neurobiology|August 1, 1994
PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonistM R Emmerling, V E Gregor, R D Schwarz, et al.
Pharmaceutica Acta Helvetiae|May 17, 2000
CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacologyH Tecle, R D Schwarz, S D Barrett, et al.
Journal of Medicinal Chemistry|July 3, 1998
Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonistH Tecle, S D Barrett, D J Lauffer, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterizationR D Schwarz, M J Callahan, L L Coughenour, et al.
The American Journal of Cardiology|February 1, 1985
Two-dimensional echocardiographically guided pericardiocentesis: experience in 117 consecutive patientsJ A Callahan, J B Seward, R A Nishimura, et al.
The American Journal of Pathology|November 14, 1997
Cerebral lipid deposition in aged apolipoprotein-E-deficient miceL C Walker, C A Parker, W J Lipinski, et al.
Molecular Neurobiology|August 1, 1994
PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonistM R Emmerling, V E Gregor, R D Schwarz, et al.
Pharmaceutica Acta Helvetiae|May 17, 2000
CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacologyH Tecle, R D Schwarz, S D Barrett, et al.
Journal of Medicinal Chemistry|July 3, 1998
Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonistH Tecle, S D Barrett, D J Lauffer, et al.
Pageof 4